Credit Suisse Ag Edwards Lifesciences Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Credit Suisse Ag holds 1,615,396 shares of EW stock, worth $109 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,615,396

Previous 1,584,062 1.98%

Holding current value

$109 Million

Previous $121 Million 27.8%

% of portfolio

0.15%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $2.27 Million - $2.99 Million	31,334 Added 1.98%	1,615,396 $154 Million
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $5.31 Million - $6.7 Million	-86,124 Reduced 5.16%	1,584,062 $121 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $8.24 Million - $11.1 Million	118,940 Added 7.67%	1,670,186 $116 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $3.22 Million - $3.73 Million	-39,517 Reduced 2.48%	1,551,246 $146 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $7.45 Million - $8.47 Million	-100,281 Reduced 5.93%	1,590,763 $132 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $3.1 Million - $3.97 Million	45,374 Added 2.76%	1,691,044 $126 Million
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $2.15 Million - $2.8 Million	-26,137 Reduced 1.56%	1,645,670 $136 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $1.18 Million - $1.75 Million	13,618 Added 0.82%	1,671,807 $159 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $9.83 Million - $12.4 Million	96,459 Added 6.18%	1,658,189 $195 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $11.5 Million - $14.2 Million	108,577 Added 7.47%	1,561,730 $202 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $16.1 Million - $19.2 Million	-156,652 Reduced 9.73%	1,453,153 $165 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $10.5 Million - $13.1 Million	125,041 Added 8.42%	1,609,805 $167 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $13.2 Million - $15.3 Million	168,361 Added 12.79%	1,484,764 $124 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $11.4 Million - $14.5 Million	159,010 Added 13.74%	1,316,403 $120 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $5.06 Million - $6.58 Million	-75,308 Reduced 6.11%	1,157,393 $92.4 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $49.7 Million - $66.5 Million	864,483 Added 234.77%	1,232,701 $85.2 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $138,362 - $213,840	-2,640 Reduced 0.71%	368,218 $69.5 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $4.51 Million - $5.16 Million	62,914 Added 20.43%	370,858 $86.5 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $406,106 - $497,687	-6,598 Reduced 2.1%	307,944 $67.7 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $3.36 Million - $3.88 Million	60,281 Added 23.71%	314,542 $58.1 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $503,898 - $673,934	-10,522 Reduced 3.97%	254,261 $48.6 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $2.45 Million - $3 Million	-52,730 Reduced 16.61%	264,783 $40.6 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $4.52 Million - $5.74 Million	-98,953 Reduced 23.76%	317,513 $55.3 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $636,283 - $768,935	14,989 Added 3.73%	416,466 $60.6 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $147,198 - $187,807	-3,958 Reduced 0.98%	401,477 $56 Million
Q4 2017 Mar 14, 2018	BUY	$33.79 - $39.39 $135,160 - $157,560	4,000 Added 1.0%	405,435 $45.7 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $472,891 - $551,263	13,995 Added 3.61%	401,435 $45.2 Million
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $2.73 Million - $2.92 Million	-75,229 Reduced 16.26%	387,440 $42.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	462,669	462,669 $54.7 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account